1. Gittes,R.F. (1991) Carcinoma of the prostate. N. Engl. J. Med., 324, 236–245.
2. Catalona,W.J. (1994) Management of cancer of the prostate. N. Engl. J. Med., 331, 996–1004.
3. Ellerhorst,J.A., Tu,S.M., Amato,R.J., Finn,L., Millikan,R.E., Pagliaro,L.C., Jackson,A. and Logothetis,C.J. (1997) Phase II trial of alternating weekly chemotherapy for patients with hormone-refractory adenocarcinoma of the prostate. Clin. Cancer Res., 3, 2371–2376.
4. Tu,S.M., Pagliaro,L.C., Banks,M.E., Amato,R.J., Millikan,R.E., Bugazia,N.A., Madden,T., Newman,R.A. and Logothetis,C.J. (1998) Phase I study of suramine combined with doxorubicin in the treatment of androgen-independent prostate cancer. Clin. Cancer Res., 4, 1193–1201.
5. Culine,S., Kattan,J., Zanetta,S., Theodore,C., Fizazi,K. and Droz,J.P. (1998) Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer. Am. J. Clin. Oncol., 21, 470–474.